Eiger BioPharmaceuticals Sponsored Study Titled 'Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV (LIMT-2)' Posted To ClinicalTrials.Gov; Study Not yet Recruiting